Yajuan Li
Principal investigator.
Biotech
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2015First federal award
$4.4MFederal grants as PI6 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
6 awards · $4.4M
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Sep 25, 2019 | NIH | SBIR Phase II Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer. | $82K | MOLECULAR THERANOSTICS, LLC |
| Aug 15, 2019 | NIH | SBIR Phase II Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer. | $1K | MOLECULAR THERANOSTICS, LLC |
| Aug 10, 2018 | NIH | SBIR Phase II Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer. | $1000K | MOLECULAR THERANOSTICS, LLC |
| Aug 1, 2017 | NIH | SBIR Phase II Commercialization of an MRI contrast agent for differential diagnosis ofprostate cancer. | $2.1M | MOLECULAR THERANOSTICS, LLC |
| Jul 26, 2017 | NIH | SBIR Phase II Commercialization of an MRI contrast agent for differential diagnosis of prostate cancer. | $1.0M | MOLECULAR THERANOSTICS, LLC |
| Jul 21, 2015 | NIH | SBIR Phase I Commercialization of targeted MRI contrast agents for prostate cancer imaging. | $250K | MOLECULAR THERANOSTICS, LLC |
Peer ranks
Federal funding#335
Awards as PI#315
Patents#273
Companies
- MOLECULAR THERANOSTICS, LLCLinked by awards · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.